These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6288441)

  • 1. Storage of the complement components C4, C3, and C 3-activator in the human liver as PAS-negative globular hyaline bodies.
    Storch W; Riedel H; Trautmann B; Justus J; Hiemann D
    Exp Pathol; 1982; 21(3):199-203. PubMed ID: 6288441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intranuclear alpha 1-antitrypsin in HBs-Ag-seronegative hepatitis B with PAS-negative globular hyaline bodies containing the complements components C4, C3, and C3-activator (author's transl)].
    Storch W; Kunze P
    Acta Histochem; 1982; 70(1):31-5. PubMed ID: 6179123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistological investigations of PAS-negative globular intracisternal hyalin in human liver biopsy specimens.
    Storch W
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 48(2):155-65. PubMed ID: 2859688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
    Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
    J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proteolytic activation systems of complement.
    Reid KB; Porter RR
    Annu Rev Biochem; 1981; 50():433-64. PubMed ID: 7023363
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I; Fujita T; Nussenzweig V
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6596-600. PubMed ID: 293746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma lewisi: restriction of alternative complement pathway C3/C5 convertase activity.
    Sturtevant JE; Balber AE
    Exp Parasitol; 1987 Jun; 63(3):260-71. PubMed ID: 3556206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoplasmic storage disease of liver: characterization of intracytoplasmic hyaline inclusions.
    Ng IO; Ng M; Lai EC; Wu PC
    Histopathology; 1989 Nov; 15(5):473-81. PubMed ID: 2480934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
    Nicholson-Weller A; Burge J; Fearon DT; Weller PF; Austen KF
    J Immunol; 1982 Jul; 129(1):184-9. PubMed ID: 6211481
    [No Abstract]   [Full Text] [Related]  

  • 10. C3 convertases of complement. Molecular genetics, structure and function of the catalytic domains, C2 and B.
    Volanakis JE
    Year Immunol; 1989; 4():218-30. PubMed ID: 2648703
    [No Abstract]   [Full Text] [Related]  

  • 11. The biochemistry of complement.
    Porter RR; Reid KB
    Nature; 1978 Oct; 275(5682):699-704. PubMed ID: 703835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum complement components in patients with trachoma.
    Sen DK; Sarin GS; Hiranandani M; Baveja UK
    Br J Ophthalmol; 1985 Sep; 69(9):707-10. PubMed ID: 3876110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of human complement components C4 and C3 with amines or chaotropic ions. Evidence of a functional and structural change that provides uncleaved C4 and C3 with properties of their soluble activated froms, C4b and C3b.
    von Zabern I; Nolte R; Vogt W
    Scand J Immunol; 1981; 13(5):413-31. PubMed ID: 6171865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
    Low PJ; Ai R; Ogata RT
    J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition.
    Santi P; Joiner KA; Hammer CH; Frank MM; Tosi R
    J Immunol; 1987 May; 138(10):3385-91. PubMed ID: 2952716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteases in complement system (author's transl)].
    Nagasawa S
    Tanpakushitsu Kakusan Koso; 1980; 25(6):531-46. PubMed ID: 7010425
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of complement factors and plasma proteins in burns].
    Angela GC; Tosco A; Giannone R; Magliacani G; Raiteri E
    Arch Sci Med (Torino); 1981; 138(1):63-92. PubMed ID: 6166276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perioperative changes of complement (C1q, C3, C4) with cardiopulmonary bypass].
    Wang YT; Xu JX; Zhu YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):86-8, 126-7. PubMed ID: 3264237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.